General Information of Drug (ID: DM49AYM)

Drug Name
S-Ethyl-N-[4-(Trifluoromethyl)Phenyl]Isothiourea Drug Info
Synonyms
TFPI hydrochloride; ETPI HCl; 163490-78-6; s-ethyl-n-[4-(trifluoromethyl)phenyl]isothiourea hydrochloride; S-Ethyl N-[4-Triflurormethyl)phenyl]isothio Urea, Hydrochloride; CHEMBL542855; SR-01000076170; EU-0101170; AC1MBZ30; C10H11F3N2S.HCl; SCHEMBL4425282; MolPort-027-641-133; 1762AH; NCGC00094428-04; NCGC00094428-03; NCGC00094428-02; NCGC00094428-01; FT-0668409; T 7188; J-010049; SR-01000076170-4; SR-01000076170-1; S-Ethyl N-[4-(trifluoromethyl)phenyl]isothiourea hydrochloride; ethyl 4-(trifluoromethyl)phenylcarbamimidothioate h
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
3311
CAS Number
CAS 163490-40-2
TTD Drug ID
DM49AYM

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
NXN-188 DMMBAIH Migraine 8A80 Phase 2 [2]
NXN-462 DMWVBS2 Headache 8A80-8A84 Phase 2 [3]
L-NIL DM6Y49D N. A. N. A. Terminated [4]
Alpha-D-Mannose DMF5DLW Discovery agent N.A. Investigative [5]
Acetate Ion DMD08RH Discovery agent N.A. Investigative [5]
Flavin-Adenine Dinucleotide DM5S4GK Discovery agent N.A. Investigative [5]
Heme DMGC287 Discovery agent N.A. Investigative [1]
Formic Acid DMNFZC6 Discovery agent N.A. Investigative [5]
2'-Monophosphoadenosine 5'-Diphosphoribose DME9S8M Discovery agent N.A. Investigative [5]
6-isobutyl-4-methylpyridin-2-amine DM2XB68 Discovery agent N.A. Investigative [6]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Nitric-oxide synthase brain (NOS1) TTZUFI5 NOS1_HUMAN Inhibitor [1]

References

1 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 ClinicalTrials.gov (NCT01748877) Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia. U.S. National Institutes of Health.
4 Discovery of a series of aminopiperidines as novel iNOS inhibitors. Bioorg Med Chem Lett. 2008 Jan 1;18(1):336-43.
5 How many drug targets are there Nat Rev Drug Discov. 2006 Dec;5(12):993-6.
6 Design and synthesis of 2-amino-4-methylpyridine analogues as inhibitors for inducible nitric oxide synthase and in vivo evaluation of [18F]6-(2-fl... J Med Chem. 2009 Apr 23;52(8):2443-53.